Nils R. Winkelmann

Jena, TH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study.

Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: December 27, 2019

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Journal: The Lancet. Haematology

Published: March 13, 2019

A Mosquito Bite with Devastating Complications in an Immunocompromised Patient.

A Mosquito Bite with Devastating Complications in an Immunocompromised Patient.

Journal: Case reports in oncology

Published: November 27, 2018

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Journal: Journal of cancer research and clinical oncology

Published: August 30, 2017

Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.

Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.

Journal: Leukemia

Published: December 09, 2016

Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients.

Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients.

Journal: Journal of cancer research and clinical oncology

Published: August 09, 2016

EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.

EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.

Journal: Journal of cancer research and clinical oncology

Published: March 16, 2016

Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Journal: Haematologica

Published: February 25, 2015

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Journal: Leukemia

Published: April 25, 2014

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Journal: British journal of haematology

Published: April 23, 2013

Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.

Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.

Journal: Leukemia & lymphoma

Published: November 29, 2012

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

Journal: Blood

Published: October 23, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026